Clonal Hematopoiesis in Patients With Human Immunodeficiency Virus and Cancer
- 24 April 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 230 (3) , 680-688
Abstract
Background: Cancer-related deaths for people with human immunodeficiency virus (PWH) are increasing due to longer life expectancies and disparately poor cancer-related outcomes. We hypothesize that advanced biological aging contributes to cancer-related morbidity and mortality for PWH and cancer. We sought to determine the impact of clonal hematopoiesis (CH) on cancer disparities in PWH. Methods: We conducted a retrospective study to compare the prevalence and clinical outcomes of CH in PWH and people without HIV (PWoH) and cancer. Included in the study were PWH and similar PWoH based on tumor site, age, tumor sequence, and cancer treatment status. Biological aging was also measured using epigenetic methylation clocks. Results: In 136 patients with cancer, PWH had twice the prevalence of CH compared to similar PWoH (23% vs 11%, P = .07). After adjusting for patient characteristics, PWH were 4 times more likely than PWoH to have CH (odds ratio, 4.1 [95% confidence interval, 1.3–13.9]; P = .02). The effect of CH on survival was most pronounced in PWH, who had a 5-year survival rate of 38% if they had CH (vs 59% if no CH), compared to PWoH who had a 5-year survival rate of 75% if they had CH (vs 83% if no CH). Conclusions: This study provides the first evidence that PWH may have a higher prevalence of CH than PWoH with the same cancers. CH may be an independent biological aging risk factor contributing to inferior survival for PWH and cancer.Keywords
Funding Information
- National Institutes of Health
- National Cancer Institute (P30-CA076292-22S3)
- National Cancer Institute (R01-CA268973)
This publication has 47 references indexed in Scilit:
- HIV Infection, Cancer Treatment Regimens, and Cancer Outcomes Among Elderly Adults in the United StatesJAMA Oncology, 2019
- Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data BaseCancer, 2019
- PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic ChemotherapyCell Stem Cell, 2018
- Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage studyThe Lancet HIV, 2017
- Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical OutcomesCell Stem Cell, 2017
- Preleukaemic clonal haemopoiesis and risk of therapy-related myeloid neoplasms: a case-control studyThe Lancet Oncology, 2017
- Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control studyThe Lancet Oncology, 2017
- Disparities in cancer treatment among patients infected with the human immunodeficiency virusCancer, 2016
- Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaborationThe Lancet, 2014
- Early Immune Senescence in HIV DiseaseCurrent HIV/AIDS Reports, 2010